Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI

NYU Langone Health

Status and phase: Completed; Phase 3

Conditions: Myocardial Infarction

Treatments: Drug: fibrinolytic therapy or combination reduced fibrinolytic therapy

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00245648

GUSTOVsex

Details and patient eligibility

About

This study evaluated differences between men and women in the presentation, management and outcome of heart attacks within the GUSTO V study.

Full description

The Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO) V trial examined a large, contemporary cohort of women and men with ST elevation myocardial infarction (STEMI) treated with fibrinolytic therapy. The objective of the present study was to evaluate sex differences in presentation, management and outcome in GUSTO V.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• inclusion into GUSTO V

Exclusion criteria

• lack of availability of data (database study)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind